Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation
RecruitingNCT06361160Phase: NAStarted 2024-05-21
Summary
Approximately 1% of the general population will be affected by schizophrenia over the course of their lives, with life expectancy being reduced by 20 years on average and quality of life being severel
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Groupe Hospitalo-Universitaire Paris Psychiatrie & NeuroscieParis, France
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06361160